This panel will address strategies for handling valuation disputes and other post-closing adjustments arising from cannabis M&A, looking at before-the-fact transactional considerations and after-the-fact litigation solutions. We will also consider the availability of state-law restructuring and turnaround remedies given the absence of federal bankruptcy protection for cannabis companies; it’s a hybrid event.
Join licensing experts from Dutchie and INCBA as they discuss New York’s newly available Adult-Use Cannabis license applications, including tips for success based on experience with prior application rounds and discussions with New York’s top cannabis regulators. This program is accredited for 1 hour of CLE.
The 2018 Farm Bill de-scheduled hemp and many cannabis operators and investors fatigued by over-regulation are exploring hemp as an alternative market for intoxicating products. But an unregulated interstate market may be even more risky than potential operators realize. Hemp law experts provide a deep dive on the current state of hemp law and policy, with practical perspectives for operators and their lawyers.
This panel provides an overview of litigation finance, explores unique aspects of cannabis litigation that make cannabis litigation finance necessary, and provides resources for cannabis attorneys and their clients as they explore litigation finance as a new
tool.
This panel will discuss, among other things: (i) the goals of implementing solid corporate governance infrastructure including transparency, equity among shareholders, and maintaining the integrity and legitimacy of a cannabis company in particular; (ii) the importance of advising clients about best practices for effectively maintaining and enforcing corporate governance systems by, including, but not limited to, adhering to the often-overlooked federal guidelines from the United States Sentencing Commission; and (iii) the importance of implementing corporate governance controls and policies during a company’s infancy; and (iv) lessons learned from high-profile cannabis companies whose poor corporate governance practices had a damaging impact, including companies like Namaste Technologies.
Hear from the panel about what “also advise” means in practice, including what federal laws are considered “related,” how to determine if federal law “conflicts” with what your client seeks to do, and how to ensure you have adequately advised your client to comply with the new Rule 1.2 provision.
This panel will cover not only the law and current developments, but also offer practical advice for traveling, consuming, and securing privilege while practicing cannabis law.
This panel seeks to get to the bottom of the IFR and what it means for the hemp CBD industry currently and in the future. We may also touch on the intersection of USDA and FDA authority to regulate hemp-derived CBD products.
Join us for an update - from the comments that INCBA has submitted to the CDFA on behalf of the industry, to the most important aspects of the regulations, and what is necessary to make appellations of origin a functional tool for consumer education and choice in the cannabis industry.